Treatment-emergent adverse events occurring in >3% of patients in the safety analysis set by CTCAE grade
| Any grade (%) | Grade 3 (%) | Grade 4 (%) | |
| Patients with any AE | 30 (96.8) | 15 (48.4) | 8 (25.8) |
| Fatigue | 22 (71.0) | ||
| Nausea | 20 (64.5) | ||
| Anorexia | 19 (61.3) | ||
| Anemia | 16 (51.6) | 9 (29.0) | 2 (6.5) |
| Thrombocytopenia | 15 (48.4) | 6 (19.4) | 5 (16.1) |
| Vomiting | 13 (41.9) | ||
| Abdominal pain | 7 (35.5) | ||
| Pruritus | 7 (22.6) | ||
| Neutropenia | 6 (19.4) | 2 (6.5) | |
| Ascites | 5 (16.1) | ||
| Non-neutropenic fever | 4 (12.9) | ||
| Dyspepsia | 4 (12.9) | ||
| Headache | 4 (12.9) |
AE, adverse event; CTCAE, Common Terminology Criteria for Adverse Event.